Reported Jan 14, 2026 · Ongoing

Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF,…

Imprimis NJOF, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Imprimis NJOF, LLC · 1705 Route 46 Ste 6B · Ledgewood, NJ · 07852-9720

Is this the product you have?

    • Dexamethasone Moxifloxacin Ketorolac
    • 1 mg/mL
    • 0.5 mg/mL
    • 0.4 mg/mL) Single-Use Intraocular Injection
    • Imprimis NJOF
    • LLC
    • 1705 Route 46 West
    • Unit 6B
    • Ledgewood
    • NJ 07852
    • NDC 71384-513-01
Lot codes and dates
  • Lot
    • 25APR001A
    • 25APR001B
  • Expires04/03/2026
Amount recalled
596 boxes of 11,920 pre-filled syringes

This recall covers 3 products

The agency filed one notice per product. You are reading one of them; the other 2 are below.

Where it was sold

  • Nationwide

Why it was recalled

Presence of particulate matter - Glass like particles.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Imprimis NJOF, LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 5:55 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.